---
schema_version: "secwatch.filing_event.v1"
accession: "0001854270-23-000079"
form_type: "8-K"
ticker: "SNTI"
cik: "0001854270"
company_name: "Senti Biosciences, Inc."
filed_at: "2023-06-23T23:59:59+00:00"
generated_at: "2026-06-13T18:27:09.434450+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "high"
source: SEC EDGAR
---

# Senti Biosciences stockholders elect three Class I directors and ratify KPMG at 2023 annual meeting

## Summary
- Timothy Lu, M.D., Ph.D. elected with 32.3M votes for; Edward Mathers elected with 22.5M for; Omid Farokhzad, M.D. elected with 26.2M for.
- KPMG LLP ratified as independent auditor for fiscal 2023 with 34.4M votes for, 60,890 against, 54,266 abstain.
- Meeting held June 16, 2023; 34.5M shares represented (78.0% of outstanding).

## SEC filing metadata
- accession: 0001854270-23-000079
- form_type: 8-K
- ticker: SNTI
- cik: 0001854270
- company_name: Senti Biosciences, Inc.
- filed_at: 2023-06-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1854270/000185427023000079/0001854270-23-000079-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1854270/000185427023000079/snti-20230616.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001854270-23-000079
- JSON: https://secwatch.observer/filing/0001854270-23-000079.json
- Plain text: https://secwatch.observer/filing/0001854270-23-000079.txt

## Key facts
- Shareholder Votes
  Senti Biosciences, Inc. shareholders approved Ratification of the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-06-16 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-16
  source text: 2. Ratification of the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2023: For Against Abstain 34,350,453 60,890 54,266
  evidence_url: https://www.sec.gov/Archives/edgar/data/1854270/000185427023000079/0001854270-23-000079-index.htm
- Shareholder Votes
  Senti Biosciences, Inc. shareholders approved Election of three Class I directors: Timothy Lu, M.D., Ph.D., Edward Mathers, and Omid Farokhzad, M.D. at the 2023-06-16 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-16
  source text: 1. Election of directors: Name For Withheld Broker Non-Votes Timothy Lu, M.D., Ph.D. 32,295,728 81,697 2,088,184 Edward Mathers 22,511,863 9,865,562 2,088,184 Omid Farokhzad, M.D. 26,184,748 6,192,677 2,088,184
  evidence_url: https://www.sec.gov/Archives/edgar/data/1854270/000185427023000079/0001854270-23-000079-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.